Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-6.83	55.79	59.88
Graham Fair Price	267.00	139667.44	38057.00
PEG	-99.30	< 0.005	0.29
Price/Book	8.95	0.45	0.41
Price/Cash Flow	527.57	5.12	0.82
Prices/Earnings	-91.32	2.86	-32.97
Price/Sales	40.30	3.31	2.36
Price/FCF	527.57	5.12	0.82
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.56	0.92	0.94
Operating Margin	34.45	0.88	0.65
ROA	1180.94	< 0.005	< 0.005
ROE	< 0.005	0.04	1155.69
ROIC	< 0.005	0.01	145.00
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	< 0.005	0.74	-99.06
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	2.56	0.08	-96.82
EPS QOQ	-1.12	14.00	1146.49
FCF QOQ	2.28	-0.82	-64.06
Revenue QOQ	0.96	-0.20	-79.66
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	1449.41	1879.86	29.70
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.88	0.87	-0.53
Quick Ratio	1.07	1.09	2.39
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	143392.43	148506.72	3.57
Cash	262049.32	254976.96	-2.70
Capex	-222.55	-217.86	2.11
Free Cash Flow	72610.03	13055.47	-82.02
Revenue	25115.17	20199.48	-19.57
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.00	0.00	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	56.36	52.11	-7.54
Naive Interpretation	Member

06 - Financial Health · Bad

Rating